Free Trial
→ Buffett’s favorite chart just hit 209% – here’s what that means for gold (From Golden Portfolio) (Ad)
NASDAQ:NRXS

NeurAxis 6/1/2023 Earnings Report

NeurAxis logo
$3.03 0.00 (0.00%)
Closing price 05/23/2025 04:00 PM Eastern
Extended Trading
$2.97 -0.06 (-2.11%)
As of 05/23/2025 07:55 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.
ProfileEarnings History

NeurAxis EPS Results

Actual EPS
-$1.18
Consensus EPS
N/A
Beat/Miss
N/A
One Year Ago EPS
N/A

NeurAxis Revenue Results

Actual Revenue
$0.81 million
Expected Revenue
N/A
Beat/Miss
N/A
YoY Revenue Growth
N/A

NeurAxis Announcement Details

Quarter
Date
6/1/2023
Time
N/A
Conference Call Date
N/A
Conference Call Time
N/A

Conference Call Resources

NeurAxis Earnings Headlines

NeurAxis, Inc. Completes $5 Million Registered Direct Offering to Support Growth of IB-Stim Therapy
May 22 at 1:27 PM | quiverquant.com
NeurAxis Announces Closing of $5.0 Million Registered Direct Offering
May 22 at 1:03 PM | globenewswire.com
Buffett’s favorite chart just hit 209% – here’s what that means for gold
A Historic Gold Announcement Is About to Rock Wall Street For months, sharp-eyed analysts have watched the quiet buildup behind the scenes. Now, in just days, the floodgates are set to open. The greatest investor of all time is about to validate what Garrett Goggin has been saying for months: Gold is entering a once-in-a-generation mania. Front-running Buffett has never been more urgent — and four tiny miners could be your ticket to 100X gains.
May 25, 2025 | Golden Portfolio (Ad)
NeurAxis, Inc. Announces $5 Million Stock Offering
May 22 at 7:18 AM | tipranks.com
Best Penny Stocks To Research - May 20th
May 22 at 4:55 AM | americanbankingnews.com
NeurAxis, Inc. Receives $1 Million from Warrant Exercises
May 21, 2025 | tipranks.com
See More NeurAxis Headlines
Get Earnings Announcements in your inbox

Want to stay updated on the latest earnings announcements and upcoming reports for companies like NeurAxis? Sign up for Earnings360's daily newsletter to receive timely earnings updates on NeurAxis and other key companies, straight to your email.

About NeurAxis

NeurAxis (NASDAQ:NRXS), a medical technology company, focuses on developing neuromodulation therapies to address chronic and debilitating conditions in children and adults in the United States. It offers IB-Stim, a percutaneous electrical nerve field stimulation system intended to be used in patients 11-18 years of age with functional abdominal pain associated with irritable bowel syndrome. The company sells its products to healthcare companies, including hospitals and clinics. The company was formerly known as Innovative Health Solutions, Inc. and changed its name to NeurAxis, Inc. in March 2022. The company was founded in 2011 and is headquartered in Carmel, Indiana.

View NeurAxis Profile

More Earnings Resources from MarketBeat

Earnings Tools
Earnings By Country
Latest Articles